Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo-Reference-Cited by-同舟云学术

Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo

Published:2013-10 Issue:41 Volume:288 Page:29562-29572
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Maussang David,Mujić-Delić Azra,Descamps Francis J.,Stortelers Catelijne,Vanlandschoot Peter,Stigter-van Walsum Marijke,Vischer Henry F.,van Roy Maarten,Vosjan Maria,Gonzalez-Pajuelo Maria,van Dongen Guus A.M.S.,Merchiers Pascal,van Rompaey Philippe,Smit Martine J.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference50 articles.

1. Pharmacological modulation of chemokine receptor function;Scholten;Br. J. Pharmacol,2012

2. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes;Balabanian;J. Biol. Chem,2005

3. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development;Burns;J. Exp. Med,2006

4. β-Arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7;Rajagopal;Proc. Natl. Acad. Sci. U.S.A,2010

5. CXCR7 functions as a scavenger for CXCL12 and CXCL11;Naumann;PLoS ONE,2010

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigational CXCR4 inhibitors in early phase development for the treatment of hematological malignancies;Expert Opinion on Investigational Drugs;2024-08-08

2. Antibodies expand the scope of angiotensin receptor pharmacology;Nature Chemical Biology;2024-05-14

3. Promising Diagnostic and Therapeutic Approaches Based on VHHs for Cancer Management;Cancers;2024-01-15

4. Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3);ACS Medicinal Chemistry Letters;2023-12-08

5. Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8;Nature Communications;2023-12-01